Journal of Clinical Endocrinology & Metabolism, Vol 74, 164-171, Copyright © 1992 by Endocrine Society

ARTICLES

An immunologically anomalous luteinizing hormone variant in a healthy woman

K Pettersson, YQ Ding and I Huhtaniemi
Wallac Immunodiagnostic Research Laboratory, University of Turku, Finland.

An investigation was undertaken to characterize an immunological LH variant in a 31-yr-old healthy woman whose serum LH was either poorly or not at all recognized by two monoclonal antibodies. The two antibodies recognize epitopes present on the intact LH dimer, but not on the free subunits. It was found that the immunologically aberrant LH of the subject was bioactive, as evidenced by an in vitro bioassay for LH. Nothing in the personal history of the subject or in the results from a number of hormone analyses revealed any endocrine abnormalities. In a GnRH stimulation test, the increase in immunoreactive LH using two reference immunometric assays for LH was less than 10% of the mean response of five control subjects. In relative terms, the maximal increase in LH in the subject was only 60-100%, in contrast to 340-560% for the control subjects. The bio/immuno ratio of the LH in the subject was high and was further increased in the GnRH stimulation test. A low proportion of acid LH isoforms in basal and stimulated samples from the subject was in agreement with the high bio/immuno ratio. Gel filtration studies showed the presence of molecular species of apparently lower molecular size than the intact LH, but different from the free beta- subunit. The results suggest the presence of fragments of the alpha- beta-dimer where at least part of the beta-subunit has been lost. A pedigree analysis involving the parents, siblings, and children of the subject strongly suggests a genetic origin of the LH variant described with an autosomal mode of inheritance. This report on an immunological variant of LH illustrates the potential dangers of using monoclonal based immunoassays where a protein hormone with fully maintained biopotency may be partially or totally missed due to the monospecificity of the immunoreagent. This possibility should be kept in mind when inappropriately low levels of gonadotropins are detected in diagnostic routine.

This article has been cited by other articles:

				A. P N Themmen An update of the pathophysiology of human gonadotrophin subunit and receptor gene mutations and polymorphisms Reproduction, September 1, 2005; 130(3): 263 - 274. [Abstract] [Full Text] [PDF]

				M. Jiang, M.-L. Savontaus, H. Simonsen, C. Williamson, R. Mullenbach, J. Gromoll, N. Terwort, M. Alevizaki, and I. Huhtaniemi Absence of the genetic variant Val79Met in human chorionic gonadotropin-beta gene 5 in five European populations Mol. Hum. Reprod., October 1, 2004; 10(10): 763 - 766. [Abstract] [Full Text] [PDF]

				T. Lamminen, M. Jiang, P. R. Manna, P. Pakarinen, H. Simonsen, R. J. Herrera, and I. Huhtaniemi Functional study of a recombinant form of human LH{beta}-subunit variant carrying the Gly102Ser mutation found in Asian populations Mol. Hum. Reprod., October 1, 2002; 8(10): 887 - 892. [Abstract] [Full Text] [PDF]

				M. Jiang, T. Lamminen, P. Pakarinen, J. Hellman, P. Manna, R. J. Herrera, and I. Huhtaniemi A novel Ala-3Thr mutation in the signal peptide of human luteinizing hormone {beta}-subunit: potentiation of the inositol phosphate signalling pathway and attenuation of the adenylate cyclase pathway by recombinant variant hormone Mol. Hum. Reprod., March 1, 2002; 8(3): 201 - 212. [Abstract] [Full Text] [PDF]

				P. R. Manna, L. Joshi, V. N. Reinhold, M. L. Aubert, N. Suganuma, K. Pettersson, and I. T. Huhtaniemi Synthesis, purification and structural and functional characterization of recombinant form of a common genetic variant of human luteinizing hormone Hum. Mol. Genet., February 1, 2002; 11(3): 301 - 315. [Abstract] [Full Text] [PDF]

				A. Akhmedkhanov, P. Toniolo, A. Zeleniuch-Jacquotte, K. S. Pettersson, and I. T. Huhtaniemi Luteinizing Hormone, Its {beta}-Subunit Variant, and Epithelial Ovarian Cancer: The Gonadotropin Hypothesis Revisited Am. J. Epidemiol., July 1, 2001; 154(1): 43 - 49. [Abstract] [Full Text] [PDF]

				M. Bergendah and J. D. Veldhuis Is there a physiological role for gonadotrophin oligosaccharide heterogeneity in humans?: III. Luteinizing hormone heterogeneity: a medical physiologist's perspective Hum. Reprod., June 1, 2001; 16(6): 1058 - 1064. [Abstract] [Full Text] [PDF]

				C.H. Nilsson, M. Kaleva, H. Virtanen, A.M. Haavisto, K. Pettersson, and I.T. Huhtaniemi Disparate response of wild-type and variant forms of LH to GnRH stimulation in individuals heterozygous for the LH{beta} variant allele Hum. Reprod., February 1, 2001; 16(2): 230 - 235. [Abstract] [Full Text] [PDF]

				A. P. N. Themmen and I. T. Huhtaniemi Mutations of Gonadotropins and Gonadotropin Receptors: Elucidating the Physiology and Pathophysiology of Pituitary-Gonadal Function Endocr. Rev., October 1, 2000; 21(5): 551 - 583. [Abstract] [Full Text]

				D.W. Cramer, K.S.I. Petterson, R.L. Barbieri, and I.T. Huhtaniemi Reproductive hormones, cancers, and conditions in relation to a common genetic variant of luteinizing hormone Hum. Reprod., October 1, 2000; 15(10): 2103 - 2107. [Abstract] [Full Text] [PDF]

				A. Akhmedkhanov, P. Toniolo, A. Zeleniuch-Jacquotte, K. Pettersson, and I. Huhtaniemi Genetic Variant of Luteinizing Hormone and Risk of Breast Cancer in Older Women Cancer Epidemiol. Biomarkers Prev., August 1, 2000; 9(8): 839 - 842. [Abstract] [Full Text]

				L.N. Ramanujam, W.-X. Liao, A.C. Roy, and S.C. Ng Association of molecular variants of luteinizing hormone with male infertility Hum. Reprod., April 1, 2000; 15(4): 925 - 928. [Abstract] [Full Text] [PDF]

				M. P. Rose, R. E. Gaines Das, and A. H. Balen Definition and Measurement of Follicle Stimulating Hormone Endocr. Rev., February 1, 2000; 21(1): 5 - 22. [Abstract] [Full Text]

				J. S. Tapanainen, R. Koivunen, B. C. J. M. Fauser, A. E. Taylor, R. N. Clayton, M. Rajkowa, D. White, S. Franks, L. Anttila, K. S. I. Pettersson, et al. A New Contributing Factor to Polycystic Ovary Syndrome: The Genetic Variant of Luteinizing Hormone J. Clin. Endocrinol. Metab., May 1, 1999; 84(5): 1711 - 1715. [Abstract] [Full Text]

				A. W. van den Beld, I. T. Huhtaniemi, K. S. L. Pettersson, H. A. P. Pols, D. E. Grobbee, F. H. de Jong, and S. W. J. Lamberts Luteinizing Hormone and Different Genetic Variants, as Indicators of Frailty in Healthy Elderly Men J. Clin. Endocrinol. Metab., April 1, 1999; 84(4): 1334 - 1339. [Abstract] [Full Text]

				P. Rodien, F. Cetani, S. Costagliola, M. Tonacchera, L. Duprez, T. Minegishi, C. Govaerts, and G. Vassart Evidences for an Allelic Variant of the Human LC/CG Receptor rather than a Gene Duplication: Functional Comparison of Wild-Type and Variant Receptors J. Clin. Endocrinol. Metab., December 1, 1998; 83(12): 4431 - 4434. [Abstract] [Full Text]

				A. Eskola-Williams and G. J. Fagan Misleading Results with Opus® Magnum hLH Assay • A spokesman from Behring replies: Clin. Chem., October 1, 1997; 43(10): 2008 - 2010. [Full Text]